// App-Quantinova.ai

98 : Improvement in GGT predicts event‐free survival in primary sclerosing cholangitis regardless of ursodeoxycholic acid treatment: data from the Pediatric PSC Consortium

Researchers

Presenter

  • Mark R. Deneau

Principal Investigators

  • Khaled Alqoaer

  • Mansi Amin

  • ACHIYA Z. AMIR

  • Marcus K. Auth

  • Fateh Bazerbachi

  • Annemarie Broderick

  • Albert Chan

  • Matthew Di Guglielmo

  • Wael El-Matary

  • Mounif El-Youssef

  • Federica Ferrari

  • Katryn Furuya

  • Madeleine Gottrand

  • Frederic Gottrand

  • Nitika A. Gupta

  • Matjaz Homan

  • M. K. Jensen

  • Binita M. Kamath

  • Kyung Mo Kim

  • Kaija-Leena Kolho

  • Anastasia Konidari

  • Bart Koot

  • Raffaele lorio

  • Cara L. Mack

  • Mercedes Martinez

  • Parvathi Mohan

  • Alexandra Papadopoulou

  • Amanda Ricciuto

  • Lawrence J. Saubermann

  • Pushpa Sathya

  • Eyal Shteyer

  • Vratislav Smolka

  • Atsushi Tanaka

  • Pamela L. Valentino

  • Raghu Varier

  • Veena Venkat

  • Bernadette Vitola

  • Miriam B. Vos

  • M. Woynarowski

  • Jason Y. Yap

  • Tamir Miloh

Medical Centers

  • Pediatric Neonatology, University of Utah, Salt Lake City, UT

  • State University of New York at Buffalo, Buffalo, NY

  • Prince Salman NW Armed Forces Hospital, Tabuk, Saudi Arabia

  • University of California, San Francisco, San Francisco, CA

  • Tel-Aviv University, Tel Aviv, Israel.

  • University of Liverpool, Liverpool, United Kingdom

  • Mayo Clinic, Rochester, MN

  • University College Dublin, Dublin 4, Ireland

  • University of Rochester, Rochester, NY

  • University Hospital of Lille, Lille, France

  • Emory University, Atlanta, GA

  • University Medical Centre Ljubljana, Ljubljana, Slovenia

  • University of Toronto, Toronto, ON, Canada

  • University of Ulsan, Seoul, Korea (the Democratic‐People's Republic of)

  • University of Helsinki, H, Finland

  • University of Manchester, Manchester, United Kingdom

  • Academic Medical Center, Amsterdam, Netherlands

  • University of Naples Federico II, Naples, Italy

  • University of Colorado Cancer Center, Aurora, CO

  • Columbia University, New York, NY

  • Children's Natl Medcl Ctr, Washington, DC

  • University of Athens, Athens, Greece

  • Memorial University, St. John's, NF, Canada

  • Shaare Zedek Medical Center, Jerusalem, Israel

  • Palacky University, Olomouc, Czech Republic

  • Teikyo University, Tokyo, Japan

  • Northwest Pediatric Gastroenterology LLC, Portland, OR

  • The Medical College of Wisconsin, Milwaukee, WI

  • The Children's Memorial Health Institute, Warsaw, Poland

  • University of Alberta, Edmonton, AB, Canada

  • Texas Childrens Hospital, Houston, TX

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Yale University, New Haven, CT

  • Thomas Jefferson University, Washington, DC

  • University of Pittsburgh Medical Center, Pittsburgh, PA

Locations

  • United States

  • Saudi Arabia

  • Israel

  • United Kingdom

  • Ireland

  • Italy

  • France

  • Slovenia

  • Canada

  • Republic of South Korea

  • Finland

  • Netherlands

  • Greece

  • Czech Republic

  • Japan

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

Disease

  • Primary sclerosing cholangitis

  • Advanced biliary tract carcinoma

  • Encephalopathy

  • Ascending cholangitis

Biomarkers

  • Gamma glutamyltransferase

Drug/Treatment

  • Ursodeoxycholic acid

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved